» Articles » PMID: 27783441

Digital Imaging Biomarkers Feed Machine Learning for Melanoma Screening

Overview
Journal Exp Dermatol
Specialty Dermatology
Date 2016 Oct 27
PMID 27783441
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

We developed an automated approach for generating quantitative image analysis metrics (imaging biomarkers) that are then analysed with a set of 13 machine learning algorithms to generate an overall risk score that is called a Q-score. These methods were applied to a set of 120 "difficult" dermoscopy images of dysplastic nevi and melanomas that were subsequently excised/classified. This approach yielded 98% sensitivity and 36% specificity for melanoma detection, approaching sensitivity/specificity of expert lesion evaluation. Importantly, we found strong spectral dependence of many imaging biomarkers in blue or red colour channels, suggesting the need to optimize spectral evaluation of pigmented lesions.

Citing Articles

The Impact of Melanoma Imaging Biomarker Cues on Detection Sensitivity and Specificity in Melanoma versus Clinically Atypical Nevi.

Aguero R, Buchanan K, Navarrete-Dechent C, Marghoob A, Stein J, Landy M Cancers (Basel). 2024; 16(17).

PMID: 39272935 PMC: 11394255. DOI: 10.3390/cancers16173077.


Hyperspectral imaging and robust statistics in non-melanoma skin cancer analysis.

Courtenay L, Gonzalez-Aguilera D, Laguela S, Del Pozo S, Ruiz-Mendez C, Barbero-Garcia I Biomed Opt Express. 2021; 12(8):5107-5127.

PMID: 34513245 PMC: 8407807. DOI: 10.1364/BOE.428143.


Diagnosis and Management of Lentigo Maligna: Clinical Presentation and Comprehensive Review.

Naik P J Skin Cancer. 2021; 2021:7178305.

PMID: 34350036 PMC: 8328731. DOI: 10.1155/2021/7178305.


Deep learning-level melanoma detection by interpretable machine learning and imaging biomarker cues.

Gareau D, Browning J, Da Rosa J, Suarez-Farinas M, Lish S, Zong A J Biomed Opt. 2020; 25(11).

PMID: 33247560 PMC: 7702097. DOI: 10.1117/1.JBO.25.11.112906.


Lentigo Maligna: Clinical Presentation and Appropriate Management.

Iznardo H, Garcia-Melendo C, Yelamos O Clin Cosmet Investig Dermatol. 2020; 13:837-855.

PMID: 33223843 PMC: 7671473. DOI: 10.2147/CCID.S224738.


References
1.
Monheit G, Cognetta A, Ferris L, Rabinovitz H, Gross K, Martini M . The performance of MelaFind: a prospective multicenter study. Arch Dermatol. 2010; 147(2):188-94. DOI: 10.1001/archdermatol.2010.302. View

2.
Hansen C, Wilkinson D, Hansen M, Argenziano G . How good are skin cancer clinics at melanoma detection? Number needed to treat variability across a national clinic group in Australia. J Am Acad Dermatol. 2009; 61(4):599-604. DOI: 10.1016/j.jaad.2009.04.021. View

3.
Salerni G, Teran T, Puig S, Malvehy J, Zalaudek I, Argenziano G . Meta-analysis of digital dermoscopy follow-up of melanocytic skin lesions: a study on behalf of the International Dermoscopy Society. J Eur Acad Dermatol Venereol. 2012; 27(7):805-14. DOI: 10.1111/jdv.12032. View

4.
Doyle-Lindrud S . Watson will see you now: a supercomputer to help clinicians make informed treatment decisions. Clin J Oncol Nurs. 2015; 19(1):31-2. DOI: 10.1188/15.CJON.31-32. View

5.
Henning J, Dusza S, Wang S, Marghoob A, Rabinovitz H, Polsky D . The CASH (color, architecture, symmetry, and homogeneity) algorithm for dermoscopy. J Am Acad Dermatol. 2006; 56(1):45-52. DOI: 10.1016/j.jaad.2006.09.003. View